• OPEN AN ACCOUNT
Indian Indices
Sensex
78,090.26 -452.18
( -0.58%)
Global Indices
Nasdaq
53,996.18 -61.75
(-0.11%)
Dow Jones
7,774.29 -4.35
(-0.06%)
Hang Seng
66,870.65 1,263.94
(1.93%)
Nikkei 225
10,869.98 -31.11
(-0.29%)
Forex
USD-INR
95.15 -0.05
(-0.05%)
EUR-INR
109.97 0.14
(0.13%)
GBP-INR
128.34 0.21
(0.16%)
JPY-INR
0.60 0.00
(0.09%)

EQUITY - MARKET SCREENER

Strides Pharma Science Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
532531
INE939A01011
356.2353295
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
STAR
51.25
9229.71
EPS(TTM)
Face Value()
Div & Yield %
19.54
10
0.5
 

GEE reports standalone net profit of Rs 3.54 crore in the March 2026 quarter
May 16,2026
Net profit of GEE reported to Rs 3.54 crore in the quarter ended March 2026 as against net loss of Rs 15.08 crore during the previous quarter ended March 2025. Sales rose 27.50% to Rs 112.16 crore in the quarter ended March 2026 as against Rs 87.97 crore during the previous quarter ended March 2025.

For the full year,net profit reported to Rs 13.00 crore in the year ended March 2026 as against net loss of Rs 9.24 crore during the previous year ended March 2025. Sales rose 10.57% to Rs 369.14 crore in the year ended March 2026 as against Rs 333.84 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales112.1687.97 27 369.14333.84 11
OPM %9.92-18.35 -9.050.25 -
PBDT10.43-18.68 LP 26.13-7.80 LP
PBT9.66-19.77 LP 22.30-11.96 LP
NP3.54-15.08 LP 13.00-9.24 LP